Angiodynamics Stock Investor Sentiment

ANGO Stock  USD 6.74  0.02  0.30%   
About 62% of all AngioDynamics' investors are looking to take a long position. The analysis of overall sentiment of trading AngioDynamics stock suggests that some investors are interested at this time. AngioDynamics' investing sentiment overview a quick insight into current market opportunities from investing in AngioDynamics. Many technical investors use AngioDynamics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  

AngioDynamics Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards AngioDynamics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
a day ago at finance.yahoo.com         
McKesson Stock Gains 34.1 percent YTD Whats Driving the Rally?
Yahoo News
2 days ago at zacks.com         
HealthEquity Gains 54.6 percent YTD Whats Driving the Stock?
zacks News
3 days ago at zacks.com         
NVRO Stock Declines Despite Positive Study Data of Nevro1 System
zacks News
six days ago at zacks.com         
GE HealthCare and DeepHealth Collaborate to Advance AI in Imaging
zacks News
over a week ago at zacks.com         
Heres Why You Should Add HealthEquity Stock to Your Portfolio Now
zacks News
over a week ago at zacks.com         
GEHC Stock Falls Despite FDA Clearance for SIGNA MAGNUS MRI System
zacks News
over a week ago at zacks.com         
Integer Holdings Gains 40.8 percent YTD Whats Driving the Stock?
zacks News
over a week ago at zacks.com         
BRKR Stock Declines Despite Launching EpicIF Technology for CellScape
zacks News
over a week ago at zacks.com         
SOLV Stock Gains as Q3 Earnings Sales Beat Estimates, 24 View Up
zacks News
over a week ago at finance.yahoo.com         
QuidelOrtho Stock Rises as Q3 Earnings Revenues Beat Estimates
Yahoo News
over two weeks ago at finance.yahoo.com         
XRAY Q3 Earnings Revenues Beat Estimates, 2024 Guidance Revised
Yahoo News
over two weeks ago at zacks.com         
MCK Stock Gains as Q2 Earnings Sales Top Estimates, 25 EPS View Up
zacks News
over two weeks ago at zacks.com         
Cencora Q4 Earnings Revenues Beat Estimates, Margins Decline YY
zacks News
over two weeks ago at finance.yahoo.com         
Tempus Stock Declines Despite Q3 Earnings Revenues Beat Estimates
Yahoo News
over two weeks ago at finance.yahoo.com         
CAH Stocks Gains on Q1 Earnings Sales Beat and Raised 25 EPS View
Yahoo News
Far too much social signal, news, headlines, and media speculation about AngioDynamics that are available to investors today. That information is available publicly through AngioDynamics media outlets and privately through word of mouth or via AngioDynamics internal channels. However, regardless of the origin, that massive amount of AngioDynamics data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of AngioDynamics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of AngioDynamics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to AngioDynamics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive AngioDynamics alpha.

AngioDynamics Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Acquisition by Chad Campbell of 8610 shares of AngioDynamics subject to Rule 16b-3
08/28/2024
2
Why AngioDynamics Stock Is Crashing Today
10/03/2024
3
AngioDynamics Loses -15.86 percent in 4 Weeks, Heres Why a Trend Reversal May be Around the Corner
10/08/2024
4
ANGO Stock Rises Following the Receipt of CPT Category I Code for IRE
10/23/2024
5
AngioDynamics launches long-term study of NanoKnife for prostate cancer
10/24/2024
6
AngioDynamics Stock Plunges 13.8 percent in Three Months Whats Next
10/29/2024
7
GE HealthCare Q3 Earnings Beat Estimates, Sales Meet, Net Margin Up
10/30/2024
8
Wall Street Analysts Believe AngioDynamics Could Rally 94.32 percent Heres is How to Trade
11/01/2024
9
Cencora Q4 Earnings Revenues Beat Estimates, Margins Decline YY
11/06/2024
10
SOLV Stock Gains as Q3 Earnings Sales Beat Estimates, 24 View Up
11/08/2024
11
Integer Holdings Gains 40.8 percent YTD Whats Driving the Stock
11/12/2024
12
GE HealthCare and DeepHealth Collaborate to Advance AI in Imaging
11/15/2024
When determining whether AngioDynamics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AngioDynamics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Angiodynamics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Angiodynamics Stock:
Check out AngioDynamics Hype Analysis, AngioDynamics Correlation and AngioDynamics Performance.
To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.
You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(6.05)
Revenue Per Share
7.249
Quarterly Revenue Growth
(0.14)
Return On Assets
(0.06)
Return On Equity
(0.78)
The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AngioDynamics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.